Transgene Biotek Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 408336,
    "name": "Transgene Biotek",
    "stock_name": "Transgene Biotek",
    "full_name": "Transgene Biotek Ltd",
    "name_url": "stocks-analysis/transgene-biotek",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.08",
    "chg": -0.18,
    "chgp": "-7.96%",
    "dir": -1,
    "prev_price": "2.26",
    "mcapval": "17.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526139,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE773D01018",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "90.09 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/transgene-biotek-408336-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3739454",
        "imagepath": "",
        "date": "2025-12-02 00:24:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Transgene Biotek’s stock has underperformed significantly against the broader market benchmarks. Over the past week, the share price has declined by 10.47%, while the Sensex has gained 0.87%. This divergence is even more pronounced over longer periods, with the stock down 9.52% in the last month compared to a 2.03% rise in the Sensex. Year-to-date, the stock has plummeted by nearly 50%, whereas the Sensex has advanced by 9.60%. Over the past year, the stock’s decline of 48.49% starkly contrasts with the Sensex’s 7.32% gain. Even over a three-year horizon, Transgene Biotek’s 18.34% return trails the Sensex’s 35.33%, and over five years, the stock has lost 30.77% while the benchmark surged 91.78%.</p>\n<p><strong>Technical Indicators S..."
      },
      {
        "title": "How has been the historical performance of Transgene Biotek?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-transgene-biotek-3702753",
        "imagepath": "",
        "date": "2025-11-14 23:31:50",
        "description": "Answer:\nThe historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years.\n\nBreakdown:\nTransge..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3686779",
        "imagepath": "",
        "date": "2025-11-10 21:20:52",
        "description": "As of 10-Nov, Transgene Biotek Ltd's stock price is currently at 3.84, reflecting an increase of 0.33 or 9.4%. The stock has shown a positive performance today, outperforming its sector by 10.98% and has been on a consecutive gain for the last two days, accumulating a total return of 13.27% during this period. However, despite this recent uptick, the stock has experienced a significant decline year-to-date of 43.78% and a 1-month drop of 7.69%. The stock's delivery volume has decreased by 2.05% compared to the 5-day average, indicating a falling investor participation, which may temper the positive momentum. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Transgene Biotek's short-term return of +1.05% over the past week contrasts with the Sensex, which has declined by 0.53% during ..."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3676529",
        "imagepath": "",
        "date": "2025-11-06 21:16:53",
        "description": "As of 06-Nov, Transgene Biotek Ltd's stock price is currently at Rs 3.36, reflecting a decline of Rs 0.22 or 6.15%. The stock has been underperforming, having lost 11.58% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, it is 4.46% away from its 52-week low of Rs 3.21. In terms of performance relative to the benchmark, the stock has seen significant declines, with a year-to-date drop of 50.81%, while the Sensex has gained 6.62% during the same period. Although there has been a notable increase in investor participation, with delivery volume rising by 79.97% against the 5-day average, the overall sentiment remains negative.\n\nBroader Market Context: In the short term, Transgene Biotek's performance has been markedly worse than the Sensex, which has only declined by 1.30% over the past week, while Transgene Biotek has dropped by 10.16%. This stark c..."
      }
    ],
    "total": 78,
    "sid": "408336",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/transgene-biotek-408336"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday 13Th February 2026",
      "datetime": "28-Jan-2026",
      "details": "Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 31st December 2025. 2) To consider and approve the Limited Review Report (Standalone & Consolidated) for the quarter ended 31st December 2025. 3) To transact such other business as may be required.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation & Variation",
      "datetime": "12-Jan-2026",
      "details": "Statement of Deviation & Variation",
      "source": "BSE"
    },
    {
      "caption": "Compliance-57 (5) : intimation after the end of quarter",
      "datetime": "12-Jan-2026",
      "details": "Compliance -57 (5)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Transgene Biotek falling/rising?

2025-12-02 00:24:46

Recent Price Movement and Market Comparison Transgene Biotek’s stock has underperformed significantly against the broader market benchmarks. Over the past week, the share price has declined by 10.47%, while the Sensex has gained 0.87%. This divergence is even more pronounced over longer periods, with the stock down 9.52% in the last month compared to a 2.03% rise in the Sensex. Year-to-date, the stock has plummeted by nearly 50%, whereas the Sensex has advanced by 9.60%. Over the past year, the stock’s decline of 48.49% starkly contrasts with the Sensex’s 7.32% gain. Even over a three-year horizon, Transgene Biotek’s 18.34% return trails the Sensex’s 35.33%, and over five years, the stock has lost 30.77% while the benchmark surged 91.78%. Technical Indicators S...

How has been the historical performance of Transgene Biotek?

2025-11-14 23:31:50

Answer: The historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years. Breakdown: Transge...

Why is Transgene Biotek falling/rising?

2025-11-10 21:20:52

As of 10-Nov, Transgene Biotek Ltd's stock price is currently at 3.84, reflecting an increase of 0.33 or 9.4%. The stock has shown a positive performance today, outperforming its sector by 10.98% and has been on a consecutive gain for the last two days, accumulating a total return of 13.27% during this period. However, despite this recent uptick, the stock has experienced a significant decline year-to-date of 43.78% and a 1-month drop of 7.69%. The stock's delivery volume has decreased by 2.05% compared to the 5-day average, indicating a falling investor participation, which may temper the positive momentum. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Transgene Biotek's short-term return of +1.05% over the past week contrasts with the Sensex, which has declined by 0.53% during ...

Why is Transgene Biotek falling/rising?

2025-11-06 21:16:53

As of 06-Nov, Transgene Biotek Ltd's stock price is currently at Rs 3.36, reflecting a decline of Rs 0.22 or 6.15%. The stock has been underperforming, having lost 11.58% over the last two days and is trading below all key moving averages, indicating a bearish trend. Additionally, it is 4.46% away from its 52-week low of Rs 3.21. In terms of performance relative to the benchmark, the stock has seen significant declines, with a year-to-date drop of 50.81%, while the Sensex has gained 6.62% during the same period. Although there has been a notable increase in investor participation, with delivery volume rising by 79.97% against the 5-day average, the overall sentiment remains negative. Broader Market Context: In the short term, Transgene Biotek's performance has been markedly worse than the Sensex, which has only declined by 1.30% over the past week, while Transgene Biotek has dropped by 10.16%. This stark c...

View All News